| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.11B | +18.0% |
| Cost of Revenue | $2.31B | +17.6% |
| Gross Profit | $1.81B | +18.6% |
| R&D Expense | $720.1M | -18.0% |
| SG&A Expense | $371.0M | -8.0% |
| Operating Income | -$218.2M | +72.5% |
| Pre-tax Income | -$120.0M | +82.8% |
| Income Tax | $9.4M | -6.9% |
| Net Income | -$129.4M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.16B | +6.6% |
| Accounts Receivable | $812.5M | -0.5% |
| Inventory | $158.3M | +71.8% |
| Current Assets | $3.23B | +5.2% |
| Total Assets | $4.30B | +1.0% |
| Current Liabilities | $1.23B | -3.4% |
| Total Liabilities | $1.81B | -6.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $218.0M | -14.8% |
| Capital Expenditures | $5.1M | -93.9% |
| Investing Cash Flow | -$25.1M | +72.9% |
| Financing Cash Flow | -$89.2M | -45.7% |
| Free Cash Flow | $213.0M | +22.9% |
| +81.8% |
| EPS (Basic) | -$0.89 | +82.2% |
| EPS (Diluted) | -$0.89 | +82.2% |
| Stockholders' Equity |
| $2.49B |
| +7.2% |